Adaptive Biotechnologies Corporation
Expert FDA Regulatory Consulting for Medtech: 510k, De Novo, PMA
Adaptive Biotechnologies Corporation is a premier regulatory consulting firm dedicated to guiding medtech companies through the complexities of FDA submissions, including 510k, de novo, and premarket approval (PMA). With a seasoned team possessing extensive expertise in regulatory affairs and strategic planning, we have a proven history of ensuring compliance and accelerating market entry. Our specialized knowledge encompasses a wide range of medical device classes and areas, including IVD, molecular diagnostics, hematology, oncology, and infectious disease diagnostics. We provide a full spectrum of services, from initial pathway and classification assessments to predicate analysis, test strategy development, and comprehensive 510k authoring.
About
**Who they are**
Adaptive Biotechnologies Corporation is a provider of expert FDA regulatory consulting services. They specialize in navigating complex regulatory pathways for medical technology companies.
**Expertise & scope**
* FDA Regulatory Consulting
* 510(k) submissions
* De Novo submissions
* PMA submissions
**Coverage**
* United States
Adaptive Biotechnologies Corporation is a provider of expert FDA regulatory consulting services. They specialize in navigating complex regulatory pathways for medical technology companies.
**Expertise & scope**
* FDA Regulatory Consulting
* 510(k) submissions
* De Novo submissions
* PMA submissions
**Coverage**
* United States
Additional information
Adaptive Biotechnologies Corporation focuses on providing specialized regulatory consulting for the medical technology sector. Their expertise is particularly geared towards helping companies prepare and submit essential documentation to the U.S. Food and Drug Administration (FDA). This includes navigating the requirements for 510(k) submissions, De Novo applications, and Premarket Approval (PMA) processes. Companies seeking to bring innovative medical devices to the U.S. market can leverage their knowledge to ensure compliance and streamline the approval process.
Key Highlights
-
Expert FDA Regulatory Consulting for Medtech
Source
“Expert FDA Regulatory Consulting for Medtech: 510k, De Novo, PMA”
-
Specializes in 510(k), De Novo, and PMA submissions
Source
“Expert FDA Regulatory Consulting for Medtech: 510k, De Novo, PMA”
-
Coverage for the United States market
Source
“Coverage: US”
-
Services provided in English
Source
“Languages: English”
Buyer Snapshot
Best for
- Medical device companies seeking FDA regulatory guidance
- Firms preparing 510(k), De Novo, or PMA submissions
How engagement typically works
- Project-based consulting for specific submissions
- Expert guidance on FDA regulatory strategy
Typical deliverables
- Regulatory submission strategy
- Prepared 510(k) documentation
- Prepared De Novo applications
- Prepared PMA applications
Good to know
- Best when requiring specialized FDA regulatory expertise for medical devices.
HQ:
United States
Languages:
English
Claim status:
Listed
Services & Capabilities
FDA 510(k) Submission Services
Jurisdictions:
US
Services Offered:
Regulatory Pathway Assessment, 510(k) Strategy & Authoring, 510(k) eSTAR Preparation, Special 510(k) Support, Traditional 510(k) Support, Abbreviated 510(k) Support, 510(k) RTA Remediation / Refuse-to-Accept Fix, Predicate Research & Substantial Equivalence Strategy, De Novo Strategy & Authoring, PMA Strategy & Support, Pre-Sub / Q-Sub Preparation, FDA Meeting Support (Q-Sub / Type C), Labeling Review for Submission (510(k)/De Novo/PMA), Submission Project Management (end-to-end)
Pathways Supported:
Traditional 510(k), Special 510(k), Abbreviated 510(k), De Novo, PMA, Pre-Sub / Q-Sub
Device Types Supported:
IVD
Supports Rta Remediation:
Yes
Supports Predicate Research:
Yes
Years Experience:
7
Num510k Submitted:
10
Ex FDA:
No
Ex Notified Body:
No
Ex Big Medtech:
Yes
Device Panels:
ivd
Technology Types:
ivd_test
Accepting New Clients:
Yes
Supports Estar:
Yes
Supports Labeling Review:
Yes
Provides Submission Project Management:
Yes
